MitoChem Therapeutics
company
About
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $2M
- Industries
- Biotechnology,Health Care,Life Science,Neuroscience,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative disease.
It was founded by Craig Beeson and Bärbel Rohrer in Charleston, South Carolina.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2M
MitoChem Therapeutics has raised a total of
$2M
in funding over 2 rounds. Their latest funding was raised on
Apr 2, 2012 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 2, 2012 | Seed | $2M | 1 |
Foundation Fighting Blindness
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
MitoChem Therapeutics is funded by 1 investors.
Foundation Fighting Blindness
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Foundation Fighting Blindness
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
